Fresh off raising a $46 million venture funding round, CloudHealth Technologies is embarking on its next chapter under new leadership.
Head of global research and development at Life Technologies
Managing Director, D.E. Shaw and Co., L.P.
VP of Research & Policy, Ewing Marion Kauffman Foundation
Vice President for Corporate Engagement, Rose-Hulman Institute of Technology
We’re pleased to bring you the third episode of Xconomy Voices, our new podcast featuring conversations with entrepreneurs, innovators, and investors from Xconomy’s home cities and regions.
Xontogeny, the Boston-based biotech startup accelerator formed by one-time Sarepta Therapeutics CEO Chris Garabedian, has taken on its first company. The firm has helped secure a $10 million investment for a Blacksburg, VA, startup, Landos Biopharma, that is developing drugs for... Read more »
A Boston-area robotics firm is starting to make its first big moves. Cambridge, MA-based “microlocation” startup Humatics announced this week it has completed an $18 million Series A funding round.
Cyber threats are mounting, and so are the investments in Boston cybersecurity companies.
Earlier this morning, Threat Stack announced it closed a $45 million funding round. Meanwhile, EiQ Networks announced today it raised $7 million in growth capital and changed... Read more »
The available drugs for neurodegenerative conditions like multiple sclerosis (MS) can only treat symptoms, or at best slow the disease’s march forward. But recent research has uncovered a new approach that could potentially address what causes nerves to break down in... Read more »
Can the life sciences industry finally begin to efficiently and systematically exploit the potential treasure trove of drugs hidden in fungi? It seems promising, thanks to cheaper DNA sequencing technologies, artificial intelligence, new academic research, and now the largest funding yet... Read more »
Research that happens at the intersection of different fields can lead to new innovations that tackle pressing problems in the life sciences. This year’s finalists in the Innovation at the Intersection category show the value of bringing different disciplines—engineering and biology,... Read more »
Here are some of the latest venture funding and acquisition headlines from the Boston innovation cluster, including a $100 million endowment for Boston University research, international expansion for Bullhorn’s recruiting software business, and an investment in a robotic furniture startup. Read... Read more »
Moderna Therapeutics, the high-flying private company with a $1 billion war chest, is reversing course. Three years ago, it decided to hatch startups as wholly-owned subsidiaries, all working on different aspects of its unproven biomedical technology called messenger RNA.
Moderna announced... Read more »
Since launching in 2014, Redox, a Madison, WI-based tech startup, has worked with other healthcare software companies to set up data feeds between their applications and the computerized patient records systems used in hospitals and clinics across the country.
Redox has... Read more »
Founding Director, Massachusetts Technology Transfer Center
Strategic Advisor, Innovation and Strategy, Citigroup
Professor, MIT Sloan School of Management
Founder and CEO, Buzzcar
Professor of the Practice, New Media Medicine, MIT Media Lab
Baker Foundation Professor, Business Administration, Harvard Business School
Writer and Consultant
Managing Director, Project 11
General Partner, Flare Capital Partners
Managing Director, CommonAngels Ventures